Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model

Sara M. AtkinsonDepartment of Immunopharmacology, Biopharmaceuticals Research Unit, Novo Nordisk A/S, Maaloev, Denmark, ;Department of Veterinary Disease Biology, Section for Experimental Animal Models, University of Copenhagen, Frederiksberg, Denmark, Correspondence[email protected] [email protected]

Anneline NansenDepartment of Immunopharmacology, Biopharmaceuticals Research Unit, Novo Nordisk A/S, Maaloev, Denmark,

Pernille A. UsherDepartment of Histology, Biopharmaceuticals Research Unit, Novo Nordisk A/S, Maaloev, Denmark,

Bodil-Cecilie SondergaardDepartment of Histology, Biopharmaceuticals Research Unit, Novo Nordisk A/S, Maaloev, Denmark,

Charles R. MackaySchool of Biomedical Sciences, Monash University, Clayton, Victoria, Australia,

Birgitte FriedrichsenDepartment of Mammalian Cell Technology, Biopharmaceuticals Research Unit, Novo Nordisk A/S, Maaloev, Denmark, and

Chih-Chuan ChangDepartment of Cell Biology, Novo Nordisk A/S, Beijing, China

Renhong TangDepartment of Cell Biology, Novo Nordisk A/S, Beijing, China

Søren SkovDepartment of Veterinary Disease Biology, Section for Experimental Animal Models, University of Copenhagen, Frederiksberg, Denmark,

Claus HaaseDepartment of Immunopharmacology, Biopharmaceuticals Research Unit, Novo Nordisk A/S, Maaloev, Denmark,

Lars HornumDepartment of Immunopharmacology, Biopharmaceuticals Research Unit, Novo Nordisk A/S, Maaloev, Denmark, Correspondence[email protected] [email protected]

show all

Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model

supplemental figure 1

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model

supplemental figure 1

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date